{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:43:26Z","timestamp":1793447006933,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"29","license":[{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King saudi university","doi-asserted-by":"crossref","award":["RSP-2020\/200"],"award-info":[{"award-number":["RSP-2020\/200"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009526","name":"Amrita Vishwa Vidyapeetham University","doi-asserted-by":"publisher","award":["K\u2010PHAR\u201020\u2010628"],"award-info":[{"award-number":["K\u2010PHAR\u201020\u2010628"]}],"id":[{"id":"10.13039\/100009526","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Environ Sci Pollut Res"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11356-021-13320-y","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T05:02:46Z","timestamp":1616216566000},"page":"38855-38866","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6658-4497","authenticated-orcid":false,"given":"Bijo","family":"Mathew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Min","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roua S.","family":"Baty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Della Grace Thomas","family":"Parambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orazio","family":"Nicolotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,20]]},"reference":[{"key":"13320_CR1","first-page":"317","volume":"28","author":"SC Baek","year":"2018","unstructured":"Baek SC, Park MH, Ryu HW, Lee JP, Kang MG, Park D, Park CM, Oh SR, Kim H (2018a) Rhamnocitrin isolated from Prunus padus var. seoulensis: a potent and selective reversible inhibitor of human monoamine oxidase A. Bioorg Chem 28:317\u2013325","journal-title":"Bioorg Chem"},{"key":"13320_CR2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bmcl.2018.01.049","volume":"15","author":"SC Baek","year":"2018","unstructured":"Baek SC, Lee HW, Ryu HW, Kang MG, Park D, Kim SH, Cho ML, Oh SR, Kim H (2018b) Selective inhibition of monoamine oxidase A by hispidol. Bioorg Med Chem Lett 15:584\u2013588","journal-title":"Bioorg Med Chem Lett"},{"key":"13320_CR3","doi-asserted-by":"crossref","first-page":"111737","DOI":"10.1016\/j.ejmech.2019.111737","volume":"183","author":"P Bai","year":"2019","unstructured":"Bai P, Wang K, Zhang P, Shi J, Cheng X, Zhang Q, Zheng C, Cheng Y, Yang J, Lu X, Sang Z (2019) Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer\u2019s disease. Eur J Med Chem 183:111737","journal-title":"Eur J Med Chem"},{"key":"13320_CR4","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcc.20292","volume":"26","author":"JL Banks","year":"2005","unstructured":"Banks JL, Beard HS, Cao Y, Cho AE, Damm W, Farid R, Felts AK, Halgren TA, Mainz DT, Maple JR, Murphy R, Philipp DM, Repasky MP, Zhang LY, Berne BJ, Friesner RA, Gallicchio E, Levy RM (2005) Integrated Modeling Program, Applied Chemical Theory (IMPACT). J Comput Chem 26:1752\u20131780","journal-title":"J Comput Chem"},{"key":"13320_CR5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","volume":"3","author":"KJ Barnham","year":"2004","unstructured":"Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3:205\u2013214","journal-title":"Nat Rev Drug Discov"},{"key":"13320_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/a-0758-0188","volume":"85","author":"A Benny","year":"2019","unstructured":"Benny A, Thomas J (2019) Essential oil as treatment for Alzheimer\u2019s disease: current and future perspectives. Planta Med 85:239\u2013248","journal-title":"Planta Med"},{"key":"13320_CR7","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1021\/jm070677y","volume":"50","author":"C Binda","year":"2007","unstructured":"Binda C, Wang J, Pisani L, Caccia C, Carotti A, Salvati P, Edmondson DE, Mattevi A (2007) Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J Med Chem 50:5848\u20135852","journal-title":"J Med Chem"},{"key":"13320_CR8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/fcp.12408","volume":"33","author":"AF Brito","year":"2019","unstructured":"Brito AF, Moreira LKS, Menegatti R, Costa EA (2019) Piperazine derivatives with central pharmacological activity used as therapeutic tools. Fundam Clin Pharmacol 33:13\u201324","journal-title":"Fundam Clin Pharmacol"},{"key":"13320_CR9","doi-asserted-by":"crossref","first-page":"6717","DOI":"10.1021\/jm501690r","volume":"58","author":"S Carradori","year":"2015","unstructured":"Carradori S, Silvestri R (2015) New frontiers in selective human MAO-B inhibitors. J Med Chem 58:6717\u20136732","journal-title":"J Med Chem"},{"key":"13320_CR10","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.3390\/molecules25225371","volume":"25","author":"M \u00c7e\u00e7en","year":"2020","unstructured":"\u00c7e\u00e7en M, Oh JM, \u00d6zdemir Z, B\u00fcy\u00fcktuncel SE, Uysal M, Abdelgawad MA, Musa A, Gambacorta N, Nicolotti O, Mathew B, Kim H (2020) Design, synthesis, and biological evaluation of pyridazinones containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors. Molecules. 25:5371","journal-title":"Molecules."},{"key":"13320_CR11","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","volume":"55","author":"J Cheung","year":"2012","unstructured":"Cheung J, Rudolph MJ, Burshteyn F, Cassidy MS, Gary EN, Love J, Franklin MC, Height JJ (2012) Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem 55:10282\u201310286","journal-title":"J Med Chem"},{"key":"13320_CR12","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1021\/jm801590u","volume":"52","author":"F Chimenti","year":"2009","unstructured":"Chimenti F, Fioravanti R, Bolasco A, Chimenti P, Secci D, Rossi F, Y\u00e1\u00f1ez M, Orallo F, Ortuso F, Alcaro S (2009) Chalcones: a valid scaffold for monoamine oxidases inhibitors. J Med Chem 52:2818\u20132824","journal-title":"J Med Chem"},{"key":"13320_CR13","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717","journal-title":"Sci Rep"},{"key":"13320_CR14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88\u201395","journal-title":"Biochem Pharmacol"},{"key":"13320_CR15","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739\u20131749","journal-title":"J Med Chem"},{"key":"13320_CR16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pneurobio.2011.04.010","volume":"94","author":"WJ Geldenhuys","year":"2011","unstructured":"Geldenhuys WJ, Youdim MB, Carroll RT, Van der Schyf CJ (2011) The emergence of designed multiple ligands for neurodegenerative disorders. Prog Neurobiol 94:347\u2013359","journal-title":"Prog Neurobiol"},{"key":"13320_CR17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discovery 10:449\u2013461","journal-title":"Expert Opin Drug Discovery"},{"key":"13320_CR18","doi-asserted-by":"crossref","first-page":"112650","DOI":"10.1016\/j.ejmech.2020.112650","volume":"205","author":"P Guglielmi","year":"2020","unstructured":"Guglielmi P, Mathew B, Secci D, Carradori S (2020) Chalcones: unearthing their therapeutic possibility as monoamine oxidase B inhibitors. Eur J Med Chem 205:112650","journal-title":"Eur J Med Chem"},{"key":"13320_CR19","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.3390\/molecules25214941","volume":"25","author":"II Jevti\u0107","year":"2020","unstructured":"Jevti\u0107 II, Lai TH, Penji\u0161evi\u0107 JZ, Duki\u0107-Stefanovi\u0107 S, Andri\u0107 DB, Brust P, Kosti\u0107-Raja\u010di\u0107 SV, Teodoro R (2020) Newly synthesized fluorinated cinnamylpiperazines possessing low in vitro MAO-B binding. Molecules 25:4941","journal-title":"Molecules"},{"key":"13320_CR20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/14756366.2016.1247054","volume":"32","author":"B Kaya","year":"2017","unstructured":"Kaya B, Yurtta\u015f L, Sa\u011flik BN, Levent S, \u00d6zkay Y, Kaplancikli ZA (2017) Novel 1-(2-pyrimidin-2-yl)piperazine derivatives as selective monoamine oxidase (MAO)-A inhibitors. J Enzyme Inhib Med Chem 32:193\u2013202","journal-title":"J Enzyme Inhib Med Chem"},{"key":"13320_CR21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bioorg.2018.01.020","volume":"77","author":"B Kumar","year":"2018","unstructured":"Kumar B, Sheetal MAK, Kumar V (2018) Synthesis, biological evaluation and molecular modeling studies of phenyl-\/benzhydrylpiperazine derivatives as potential MAO inhibitors. Bioorg Chem 77:252\u2013262","journal-title":"Bioorg Chem"},{"key":"13320_CR22","doi-asserted-by":"crossref","first-page":"103043","DOI":"10.1016\/j.bioorg.2019.103043","volume":"89","author":"JP Lee","year":"2019","unstructured":"Lee JP, Kang MG, Lee JY, Oh JM, Baek SC, Leem HH, Park D, Cho ML, Kim H (2019) Potent inhibition of acetylcholinesterase by sargachromanol I from Sargassum siliquastrum and by selected natural compounds. Bioorg Chem 89:103043","journal-title":"Bioorg Chem"},{"key":"13320_CR23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787\u2013795","journal-title":"Nature"},{"key":"13320_CR24","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3109\/14756366.2015.1050009","volume":"31","author":"H Liu","year":"2016","unstructured":"Liu H, Fan H, Gao X, Huang X, Liu X, Liu L, Zhou C, Tang J, Wang Q, Liu W (2016) Design, synthesis and preliminary structure-activity relationship investigation of nitrogen-containing chalcone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: a further study based on Flavokawain B Mannich base derivatives. J Enzyme Inhib Med Chem 31:580\u2013589","journal-title":"J Enzyme Inhib Med Chem"},{"key":"13320_CR25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234","journal-title":"J Comput Aided Mol Des"},{"key":"13320_CR26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejps.2017.02.008","volume":"101","author":"GF Mangiatordi","year":"2017","unstructured":"Mangiatordi GF, Alberga D, Pisani L, Gadaleta D, Trisciuzzi D, Farina R, Carotti A, Lattanzi G, Catto M, Nicolotti O (2017) A rational approach to elucidate human monoamine oxidase molecular selectivity. Eur J Pharm Sci 101:90\u201399","journal-title":"Eur J Pharm Sci"},{"key":"13320_CR27","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2174\/1386207323999200728122627","volume":"23","author":"B Mathew","year":"2020","unstructured":"Mathew B (2020) Privileged pharmacophore of FDA approved drugs in combination with chalcone framework: a new hope for Alzheimer\u2019s treatment. Comb Chem High Throughput Screen 23:842\u2013846","journal-title":"Comb Chem High Throughput Screen"},{"key":"13320_CR28","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ijbiomac.2016.05.110","volume":"91","author":"B Mathew","year":"2016","unstructured":"Mathew B, Haridas A, U\u00e7ar G, Baysal I, Adeniyi AA, Soliman ME, Joy M, Mathew GE, Lakshmanan B, Jayaprakash V (2016) Exploration of chlorinated thienyl chalcones: a new class of monoamine oxidase-B inhibitors. Int J Biol Macromol 91:680\u2013695","journal-title":"Int J Biol Macromol"},{"key":"13320_CR29","first-page":"522","volume":"20","author":"B Mathew","year":"2017","unstructured":"Mathew B, Mathew GE, Petzer JP, Petzer A (2017) Structural exploration of synthetic chromones as selective MAO-B inhibitors: a mini review. Comb Chem High Throughput Screen 20:522\u2013532","journal-title":"Comb Chem High Throughput Screen"},{"key":"13320_CR30","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1039\/C8MD00399H","volume":"9","author":"B Mathew","year":"2018","unstructured":"Mathew B, Baek SC, Grace Thomas Parambi D, Lee JP, Joy M, Annie Rilda PR, Randev RV, Nithyamol P, Vijayan V, Inasu ST, Mathew GE, Lohidakshan KK, Kumar Krishnan G, Kim H (2018) Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors. MedChemComm 9:1871\u20131881","journal-title":"MedChemComm"},{"key":"13320_CR31","doi-asserted-by":"crossref","first-page":"e1800309","DOI":"10.1002\/ardp.201800309","volume":"352","author":"B Mathew","year":"2019","unstructured":"Mathew B, Baek SC, Thomas Parambi DG, Lee JP, Mathew GE, Jayanthi S, Vinod D, Rapheal C, Devikrishna V, Kondarath SS, Uddin MS, Kim H (2019a) Potent and highly selective dual-targeting monoamine oxidase-B inhibitors: fluorinated chalcones of morpholine versus imidazole. Arch Pharm (Weinheim) 352:e1800309","journal-title":"Arch Pharm (Weinheim)"},{"key":"13320_CR32","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2174\/1871527318666190610111246","volume":"18","author":"B Mathew","year":"2019","unstructured":"Mathew B, Parambi DGT, Sivasankarapillai VS, Uddin MS, Suresh J, Mathew GE, Joy M, Marathakam A, Gupta SV (2019b) Perspective design of chalcones for the management of CNS disorders: a mini-review. CNS Neurol Disord Drug Targets 18:432\u2013445","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"13320_CR33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2174\/0929867327666200121165931","volume":"28","author":"B Mathew","year":"2020","unstructured":"Mathew B, Carradori S, Guglielmi P, Uddin MS, Kim H (2020) New aspects of monoamine oxidase B inhibitors: the key role of halogens to open the golden door. Curr Med Chem 28:266\u2013283. https:\/\/doi.org\/10.2174\/0929867327666200121165931","journal-title":"Curr Med Chem"},{"key":"13320_CR34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1517\/13543776.2014.995627","volume":"25","author":"MJ Matos","year":"2015","unstructured":"Matos MJ, Vazquez-Rodriguez S, Uriarte E, Santana L (2015) Potential pharmacological uses of chalcones: a patent review (from June 2011 - 2014). Expert Opin Ther Pat 25:351\u2013366","journal-title":"Expert Opin Ther Pat"},{"key":"13320_CR35","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/ardp.201300242","volume":"346","author":"RP Modh","year":"2013","unstructured":"Modh RP, Kumar SP, Jasrai YT, Chikhalia KH (2013) Design, synthesis, biological evaluation, and molecular modeling of coumarin-piperazine derivatives as acetylcholinesterase inhibitors. Arch Pharm (Weinheim) 346:793\u2013804","journal-title":"Arch Pharm (Weinheim)"},{"key":"13320_CR36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/cbdd.12458","volume":"85","author":"N Morales-Camilo","year":"2015","unstructured":"Morales-Camilo N, Salas CO, Sanhueza C, Espinosa-Bustos C, Sep\u00falveda-Boza S, Reyes-Parada M, Gonzalez-Nilo F, Caroli-Rezende M, Fierro A (2015) Synthesis, biological evaluation, and molecular simulation of chalcones and aurones as selective MAO-B inhibitors. Chem Biol Drug Des 85:685\u2013695","journal-title":"Chem Biol Drug Des"},{"key":"13320_CR37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/med.21622","volume":"40","author":"NM Moussa-Pacha","year":"2019","unstructured":"Moussa-Pacha NM, Abdin SM, Omar HA, Alniss H, Al-Tel TH (2019) BACE1 inhibitors: current status and future directions in treating Alzheimer\u2019s disease. Med Res Rev 40:339\u2013384","journal-title":"Med Res Rev"},{"key":"13320_CR38","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.3390\/molecules25102356","volume":"25","author":"JM Oh","year":"2020","unstructured":"Oh JM, Rangarajan TM, Chaudhary R, Singh RP, Singh M, Singh RP, Tondo AR, Gambacorta N, Nicolotti O, Mathew B, Kim H (2020) Novel class of chalcone oxime ethers as potent monoamine oxidase-B and acetylcholinesterase inhibitors. Molecules 25:2356","journal-title":"Molecules"},{"key":"13320_CR39","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s43440-020-00070-w","volume":"72","author":"Z \u00d6zdemir","year":"2020","unstructured":"\u00d6zdemir Z, Alag\u00f6z MA, Uslu H, Karakurt A, Erikci A, Ucar G, Uysal M (2020) Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors. Pharmacol Rep 72:692\u2013704","journal-title":"Pharmacol Rep"},{"key":"13320_CR40","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1021\/jm201692d","volume":"55","author":"F Pettersson","year":"2012","unstructured":"Pettersson F, Svensson P, Waters S, Waters N, Sonesson C (2012) Synthesis and evaluation of a set of para-substituted 4-phenylpiperidines and 4-phenylpiperazines as monoamine oxidase (MAO) inhibitors. J Med Chem 55:3242\u20133249","journal-title":"J Med Chem"},{"key":"13320_CR41","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/13543776.2016.1189902","volume":"26","author":"AK Rathi","year":"2016","unstructured":"Rathi AK, Syed R, Shin HS, Patel RV (2016) Piperazine derivatives for therapeutic use: a patent review (2010-present). Expert Opin Ther Pat 26:777\u2013797","journal-title":"Expert Opin Ther Pat"},{"key":"13320_CR42","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2174\/1871527318666190906101326","volume":"18","author":"Reeta","year":"2019","unstructured":"Reeta, Baek SC, Lee JP, Rangarajan TM, Ayushee, Singh RP, Singh M, Mangiatordi GF, Nicolotti O, Kim H, Mathew B (2019) Ethyl acetohydroxamate incorporated chalcones: unveiling a novel class of chalcones for multitarget monoamine oxidase-B inhibitors against Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 18:643\u2013654","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"13320_CR43","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1016\/j.bmcl.2013.06.050","volume":"23","author":"SJ Robinson","year":"2013","unstructured":"Robinson SJ, Petzer JP, Petzer A, Bergh JJ, Lourens AC (2013) Selected furanochalcones as inhibitors of monoamine oxidase. Bioorg Med Chem Lett 23:4985\u20134989","journal-title":"Bioorg Med Chem Lett"},{"key":"13320_CR44","doi-asserted-by":"crossref","first-page":"E4342","DOI":"10.3390\/molecules25184342","volume":"25","author":"BN Sa\u011fl\u0131k","year":"2020","unstructured":"Sa\u011fl\u0131k BN, Cebeci O, Acar \u00c7evik U, Osmaniye D, Levent S, Kaya \u00c7avu\u015fo\u011flu B, Ilg\u0131n S, \u00d6zkay Y, Kaplanc\u0131kl\u0131 ZA (2020) Design, synthesis, in vitro and in silico studies of new thiazolylhydrazine-piperazine derivatives as selective MAO-A inhibitors. Molecules 25:E4342","journal-title":"Molecules"},{"key":"13320_CR45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ddr.21481","volume":"79","author":"Z Sahin","year":"2018","unstructured":"Sahin Z, Ertas M, Bender C, B\u00fclb\u00fcl EF, Berk B, Biltekin SN, Yurtta\u015f L, Demirayak \u015e (2018) Thiazole-substituted benzoylpiperazine derivatives as acetylcholinesterase inhibitors. Drug Dev Res 79:406\u2013425","journal-title":"Drug Dev Res"},{"key":"13320_CR46","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ardp.201600088","volume":"349","author":"R Sasidharan","year":"2016","unstructured":"Sasidharan R, Manju SL, U\u00e7ar G, Baysal I, Mathew B (2016) Identification of indole-based chalcones: discovery of a potent, selective, and reversible class of MAO-B inhibitors. Arch Pharm (Weinheim) 349:627\u2013637","journal-title":"Arch Pharm (Weinheim)"},{"key":"13320_CR47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopha.2018.06.064","volume":"106","author":"R Sasidharan","year":"2018","unstructured":"Sasidharan R, Baek SC, Sreedharannair Leelabaiamma M, Kim H, Mathew B (2018) Imidazole bearing chalcones as a new class of monoamine oxidase inhibitors. Biomed Pharmacother 106:8\u201313","journal-title":"Biomed Pharmacother"},{"key":"13320_CR48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/14756366.2020.1842390","volume":"36","author":"R Sasidharan","year":"2021","unstructured":"Sasidharan R, Eom BH, Heo JH, Park JE, Abdelgawad MA, Musa A, Gambacorta N, Nicolotti O, Manju SL, Mathew B, Kim H (2021) Morpholine based chalcones as dual acting monoamine oxidase-B and acetylcholinesterase inhibitors. Synthesis and biochemical investigations. J Enzyme Inhib Med Chem 36:188\u2013197","journal-title":"J Enzyme Inhib Med Chem"},{"key":"13320_CR49","unstructured":"Schr\u00f6dinger Release 2020-4 (2020a) Glide, Schr\u00f6dinger. LLC"},{"key":"13320_CR50","volume-title":"LigPrep, Schr\u00f6dinger","author":"Schr\u00f6dinger Release 2020-4","year":"2020","unstructured":"Schr\u00f6dinger Release 2020-4 (2020b) LigPrep, Schr\u00f6dinger. LLC, New York"},{"key":"13320_CR51","unstructured":"Schr\u00f6dinger Release 2020-4: (2020c) Protein Preparation Wizard; Epik, Schr\u00f6dinger, LLC, New York, NY, 2016; Impact, Schr\u00f6dinger, LLC, New York, NY, 2016; Prime, Schr\u00f6dinger, LLC, New York, NY."},{"key":"13320_CR52","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/14756366.2019.1593158","volume":"34","author":"R Shalaby","year":"2019","unstructured":"Shalaby R, Petzer JP, Petzer A, Ashraf UM, Atari E, Alasmari F, Kumarasamy S, Sari Y, Khalil A (2019) SAR and molecular mechanism studies of monoamine oxidase inhibition by selected chalcone analogs. J Enzyme Inhib Med Chem 34:863\u2013876","journal-title":"J Enzyme Inhib Med Chem"},{"key":"13320_CR53","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1073\/pnas.0710626105","volume":"105","author":"SY Son","year":"2008","unstructured":"Son SY (2008) Ma J, Kondou Y, Yoshimura M, Yamashita E, Tsukihara T (2008). Structure of human monoamine oxidase A at 2.2-A resolution: the control of opening the entry for substrates\/inhibitors. Proc Natl Acad Sci U S A 105:5739\u20135744","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13320_CR54","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00702-018-1881-5","volume":"125","author":"KF Tipton","year":"2018","unstructured":"Tipton KF (2018) 90 years of monoamine oxidase: some progress and some confusion. J Neural Transm (Vienna) 125:1519\u20131551","journal-title":"J Neural Transm (Vienna)"},{"key":"13320_CR55","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1016\/j.bmcl.2007.08.021","volume":"17","author":"V Tomar","year":"2007","unstructured":"Tomar V, Bhattacharjee G, Kamaluddin KA (2007) Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety. Bioorg Med Chem Lett 17:5321\u20135324","journal-title":"Bioorg Med Chem Lett"},{"key":"13320_CR56","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3390\/ijms20030719","volume":"20","author":"M Van Bulck","year":"2019","unstructured":"Van Bulck M, Sierra-Magro A, Alarcon-Gil J, Perez-Castillo A, Morales-Garcia JA (2019) Novel approaches for the treatment of Alzheimer\u2019s and Parkinson\u2019s disease. Int J Mol Sci 20:719","journal-title":"Int J Mol Sci"},{"key":"13320_CR57","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.bmc.2016.12.013","volume":"25","author":"G Xiao","year":"2017","unstructured":"Xiao G, Li Y, Qiang X, Xu R, Zheng Y, Cao Z, Luo L, Yang X, Sang Z, Su F, Deng Y (2017) Design, synthesis and biological evaluation of 4'-aminochalcone-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease. Bioorg Med Chem 25:1030\u20131041","journal-title":"Bioorg Med Chem"},{"key":"13320_CR58","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejmech.2019.05.020","volume":"176","author":"P Zhang","year":"2019","unstructured":"Zhang P, Xu S, Zhu Z, Xu J (2019) Multi-target design strategies for the improved treatment of Alzheimer\u2019s disease. Eur J Med Chem 176:228\u2013247","journal-title":"Eur J Med Chem"},{"key":"13320_CR59","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","volume":"117","author":"C Zhuang","year":"2017","unstructured":"Zhuang C, Zhang W, Sheng C, Zhang W, Xing C, Miao Z (2017) Chalcone: a privileged structure in medicinal chemistry. Chem Rev 117:7762\u20137810","journal-title":"Chem Rev"}],"container-title":["Environmental Science and Pollution Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-021-13320-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11356-021-13320-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-021-13320-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T18:42:12Z","timestamp":1744137732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11356-021-13320-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,20]]},"references-count":59,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["13320"],"URL":"https:\/\/doi.org\/10.1007\/s11356-021-13320-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-158102\/v1","asserted-by":"object"}]},"ISSN":["0944-1344","1614-7499"],"issn-type":[{"value":"0944-1344","type":"print"},{"value":"1614-7499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,20]]},"assertion":[{"value":"26 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}